By Samuel Indyk
Deliveroo (LON:ROO) – Pharmacy chain Boots is to make some products available through Deliveroo as part of a trial scheme launching today.
Wood Group (LON:WG) – H1 revenue down 22.9% to $3.15 billion. Operating profit up 3.0% to $68 million. Order book up around 18% compared to December to $7.687 billion. Full year outlook unchanged. Sees annual revenue of $6.6-6.8 billion, below last year’s $7.56 billion.
PureTech Health (LON:PRTC) – Continued advancement of PureTech’s Wholly Owned Programs, with two Phase 2 and four Phase 1 clinical trials underway. Key preclinical data published in peer-reviewed journals for two of PureTech’s four lymphatic and inflammation platforms. Consolidated cash and cash equivalents at 30th June were $439.8 million.
Spectris (LON:SXS) – Agreed to sell NDC Technologies unit to Nordson for $180 million. Proceeds used to strengthen balance sheet and then be deployed in accordance with capital allocation policy.
Essensys (LON:ESYS) – Continued growth in recurring revenues, up to 87%. Group revenue increased 2% to £22.9 million. Performance was in line with expectations.
Hunting (LON:HTG) – Invests $5.0 million in Cumberland Additive Holdings to access the additive manufacturing sector.
UK market update – Deliveroo begins Boots trial, Wood Group sees lower revenue
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.